期刊
NANOMEDICINE
卷 10, 期 3, 页码 447-463出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm.14.179
关键词
carrier-mediated agents; clearance; Doxil; nanoparticles; pharmacokinetics; S-CKD602
资金
- National Cancer Institute of the NIH [U54CA151652]
- University of North Carolina University Cancer Research Fund
Major advances in carrier-mediated agents, which include nanoparticles, nanosomes and conjugates, have revolutionized drug delivery capabilities over the past decade. While providing numerous advantages, such as greater solubility, duration of exposure and delivery to the site of action over their small-molecule counterparts, there is substantial variability in systemic clearance and distribution, tumor delivery and pharmacologic effects (efficacy and toxicity) of these agents. This review provides an overview of factors that affect the pharmacokinetics and pharmacodynamics of carrier-mediated agents in preclinical models and patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据